Speaking from the British Oncology Pharmacy Association (BOPA) 20th Annual Symposium 2017 in Glasgow, UK, Islam Elkonaissi of The Royal Marsden NHS Foundation Trust, London, UK discusses how pharmacists play an important role in the introduction and effective utilization of new drugs for pancreatic cancer. Mr Elkonaissi highlights how meetings such as BOPA aid in this process.
The role of pharmacists in utilizing novel pancreatic cancer treatments
